![Martin Welschof](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Welschof
Directeur Général chez
BIOINVENT INTERNATIONAL AB
Fortune : 53 145 $ au 31/08/2026
Profil
Martin Welschof was the founder of Affitech AS, founded in 1997, and Affitech A, founded in 2003, where the title of Chief Executive Officer was held from 2003 to 2009.
Current jobs include Chief Executive Officer at BioInvent International AB since 2018, Director at Anocca AB, Director at Uni Targeting Research AS since 2007, Director at Nextera AS since 2013, and Director at APIM Therapeutics AS since 2015.
Former jobs include Chief Executive Officer at Opsona Therapeutics Ltd. from 2012 to 2018, Technology Director at Axaron Bioscience AG from 1997 to 2002, Director at ExpreS2ion Biotechnologies ApS, Director at Zelluna Immunotherapy AS, and Principal at Lynx Therapeutics, Inc. Education includes a doctorate from the University of Bielefeld, conferred in 1996.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2025 | 22 400 ( 0,03% ) | 53 145 $ | 31/08/2026 |
Postes actifs de Martin Welschof
| Sociétés | Poste | Début |
|---|---|---|
| BIOINVENT INTERNATIONAL AB | Directeur Général | 01/09/2018 |
Nextera AS
 Nextera AS Miscellaneous Commercial ServicesCommercial Services Provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer | Directeur/Membre du Conseil | 01/01/2013 |
Uni Targeting Research AS
 Uni Targeting Research AS BiotechnologyHealth Technology Provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures | Directeur/Membre du Conseil | 01/01/2007 |
APIM Therapeutics AS
 APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology Develops and commercializes novel anti-cancer therapies | Directeur/Membre du Conseil | 01/06/2015 |
Anocca AB
 Anocca AB Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company developing next-generation immunotherapies | Directeur/Membre du Conseil | - |
Anciens postes connus de Martin Welschof
| Sociétés | Poste | Fin |
|---|---|---|
Opsona Therapeutics Ltd.
 Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides immunology drug for treatment of inflammatory diseases | Directeur Général | 01/07/2018 |
Affitech AS /Old/
 Affitech AS /Old/ Miscellaneous Commercial ServicesCommercial Services Discovers and develops human therapeutic antibodies | Fondateur | 15/06/2009 |
Affitech A/S
 Affitech A/S Pharmaceuticals: MajorHealth Technology Researches and develops human antibody therapeutics | Directeur Général | 01/01/2009 |
Axaron Bioscience AG
 Axaron Bioscience AG Miscellaneous Commercial ServicesCommercial Services Develops biotechnologies | Directeur Technique/Scientifique/R&D | 01/01/2002 |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Martin Welschof
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Lynx Therapeutics, Inc.
 Lynx Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops genetic analysis products for the pharmaceutical, biotechnology and agriculture industries | Health Technology |
BioInvent International AB
 BioInvent International AB BiotechnologyHealth Technology Develops and manufactures immunomodulatory antibodies for cancer treatment | Health Technology |
Affitech AS /Old/
Affitech AS /Old/ Miscellaneous Commercial ServicesCommercial Services Discovers and develops human therapeutic antibodies | Commercial Services |
University of Bielefeld
 University of Bielefeld Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Uni Targeting Research AS
Uni Targeting Research AS BiotechnologyHealth Technology Provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures | Health Technology |
Opsona Therapeutics Ltd.
Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides immunology drug for treatment of inflammatory diseases | Health Technology |
Affitech A/S
Affitech A/S Pharmaceuticals: MajorHealth Technology Researches and develops human antibody therapeutics | Health Technology |
Axaron Bioscience AG
Axaron Bioscience AG Miscellaneous Commercial ServicesCommercial Services Develops biotechnologies | Commercial Services |
Nextera AS
Nextera AS Miscellaneous Commercial ServicesCommercial Services Provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer | Commercial Services |
APIM Therapeutics AS
APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology Develops and commercializes novel anti-cancer therapies | Health Technology |
ExpreS2ion Biotechnologies ApS
 ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells | Health Technology |
Zelluna Immunotherapy AS
 Zelluna Immunotherapy AS BiotechnologyHealth Technology Engages in development of off the shelf T-cell receptor natural killer cell therapies | Health Technology |
Anocca AB
Anocca AB Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company developing next-generation immunotherapies | Commercial Services |
